Monkeypox Virus: Biology, Clinical Relevance, and Nucleic Acid Detection

Monkeypox virus belongs to the family Poxviridae, genus Orthopoxvirus. It is an enveloped or partially enveloped virus with the typical orthopoxvirus morphology, usually described as brick-shaped or ovoid, with a particle size of approximately 200–400 nm.

The viral genome consists of linear double-stranded DNA of about 196 kb. The genome contains terminal inverted repeat regions and encodes a large number of open reading frames. The central genomic region is highly conserved among orthopoxviruses and contains genes essential for viral replication and structural protein formation, whereas terminal genomic regions are more variable and are associated with virulence, host range, and immune evasion.

Two major genetic clades have historically been recognized: the Central African clade and the West African clade. These lineages differ in epidemiological behavior and disease severity, with the Central African lineage generally associated with higher mortality and more severe clinical disease.

Monkeypox virus is a zoonotic pathogen, and animal-to-human transmission was the basis of the earliest recognized infections. Human infection can occur through direct contact with infected animals, contaminated materials, or infectious lesions. Secondary human-to-human transmission also occurs and may involve close physical contact, respiratory secretions, lesion material, or contaminated fomites.

The incubation period is commonly around 7 to 14 days, although variation is possible. Clinical spread is influenced by contact patterns, exposure to lesion material, and the infectious stage of disease. In outbreak settings, rapid laboratory confirmation is important for case identification, surveillance, and containment.

For laboratory testing, appropriate specimen types include lesion swabs, vesicular or pustular fluid, crusts, and upper respiratory specimens such as oropharyngeal or nasopharyngeal secretions when relevant to the testing workflow.

Human monkeypox infection typically begins with a febrile prodrome that may include fever, myalgia, chills, fatigue, and lymphadenopathy. Lymph node enlargement is an important clinical feature that may help distinguish monkeypox from some other orthopoxvirus infections.

This prodromal phase is followed by the development of a rash, often involving the face, extremities, or genital region. Lesions may progress through macular, papular, vesicular, pustular, and crusting stages. Patients can experience painful or pruritic lesions, and disease duration often extends for several weeks.

Although many patients recover without specific antiviral therapy, severe disease can occur in certain populations. Clinical severity may vary by viral lineage, host immune status, and underlying health conditions. Because the symptoms can overlap with those of varicella, other orthopoxvirus infections, and some sexually transmitted infections with rash, laboratory diagnosis is essential.

Laboratory diagnosis of monkeypox virus can be performed by nucleic acid testing or by viral culture. Viral culture can provide direct isolation of the pathogen, but it requires high-level biosafety infrastructure and is therefore not practical for routine widespread testing.

Probe-based real-time PCR is the preferred molecular method for rapid and sensitive detection of monkeypox virus DNA. This approach is suitable for testing lesion material, vesicle fluid, crust specimens, and selected respiratory samples. Real-time PCR offers high analytical sensitivity, strong specificity, and compatibility with outbreak surveillance, research workflows, and differential diagnosis.

Strain- or clade-targeted molecular assays are also valuable in epidemiological studies and lineage-specific detection. In situations where lineage differentiation is important, dedicated assays for the West African strain can support more refined molecular characterization.

Management of monkeypox virus infection relies on supportive care, isolation precautions, and careful clinical monitoring. Most cases are self-limited, but severe disease may require more intensive management, particularly in immunocompromised individuals, children, pregnant patients, or those with extensive lesions.

From a laboratory and public health perspective, early nucleic acid detection is one of the most important tools for outbreak response. Prompt identification of viral DNA in appropriate specimens supports case confirmation, contact tracing, infection control, and research into viral circulation patterns.

Because viral culture is restricted by biosafety requirements, molecular testing remains the most practical and scalable option for routine detection and screening in many laboratory settings.